Vaxil Bio Ltd.
VXL.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 378.50K | 489.40K | 320.90K | 254.40K | 280.40K |
| Total Receivables | 58.90K | 2.20K | 112.00K | 203.80K | 195.50K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 8.00K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 437.40K | 499.60K | 432.90K | 458.30K | 475.90K |
|
|
|||||
| Total Current Assets | 437.40K | 499.60K | 432.90K | 458.30K | 475.90K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 929.40K | 999.20K | 484.60K | 511.10K | 475.90K |
|
|
|||||
| Total Accounts Payable | 20.10K | 2.20K | 2.20K | 700.00 | 24.40K |
| Total Accrued Expenses | 5.70K | 1.50K | 3.60K | 3.70K | 3.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 25.90K | 3.60K | 5.70K | 4.40K | 27.80K |
|
|
|||||
| Total Current Liabilities | 25.90K | 3.60K | 5.70K | 4.40K | 27.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.90K | 3.60K | 5.70K | 4.40K | 27.80K |
|
|
|||||
| Common Stock & APIC | 11.58M | 11.76M | 11.54M | 11.79M | 11.18M |
| Retained Earnings | -13.73M | -13.87M | -14.06M | -14.34M | -13.64M |
| Treasury Stock & Other | 3.05M | 3.10M | 3.00M | 3.06M | 2.90M |
| Total Common Equity | 903.50K | 995.50K | 478.90K | 506.70K | 448.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 903.50K | 995.50K | 478.90K | 506.70K | 448.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 903.50K | 995.50K | 478.90K | 506.70K | 448.00K |
|
|
|||||